Myeloma Minute: Your Guide to Upcoming IMF Activities


| INNOVATION | Teleconference


Register Now for the Post-ASCO/EHA/IMWG Teleconference

Learn the latest from three major medical meetings held in June 2019. Dr. Brian G.M. Durie will explain what’s new and exciting from the:

  • American Society of Clinical Oncology (ASCO),
  • European Hematology Association (EHA), and
  • International Myeloma Working Group Summit (IMWG).

You won’t want to miss this free IMF teleconference followed by a Q&A session! Save the date and register now.

Register Now Button.png



Watch and Learn About the Latest Research from ASCO 2019

The IMF captured video footage from top myeloma experts at this past weekend’s American Society of Clinical Oncology Annual Meeting in Chicago. You can view Dr. María V. Mateos speaking about Abstract #8000; ASCO overviews by Drs. Rafat Abonour, S. Vincent Rajkumar, and Paul Richardson; and more.


| EDUCATION | Workshop


| EDUCATION | Publication


Register Now for a Regional Community Workshop in Pittsburgh
Hot Off the Press: Understanding Peripheral Neuropathy in Myeloma Booklet

The IMF will host a Regional Community Workshop at The Westin (1000 Penn Ave.) in Pittsburgh on Saturday, June 29, 2019. Registration is FREE, but seating is limited. Learn from and meet one-on-one with myeloma experts to get answers to your questions and concerns.

The Understanding Peripheral Neuropathy in Myeloma booklet is designed to help myeloma patients either manage peripheral neuropathy or prevent its onset. Visit the link below to download a FREE PDF of this booklet!

Register Now Button.png


| ADVOCACY | Oral Parity


Send a Message to Congress About Cancer Drug Parity

On Wednesday, June 12th, the Coalition to Improve Access to Cancer Care (CIACC) will visit Capitol Hill. The CIACC will meet with congressional members and their staff to ask for their support of the Cancer Drug Parity Act of 2019. The Act corrects a disparity in insurance benefit design for commercial plans. Patients on oral or self-administered anticancer medication face more expensive cost-sharing than those on traditional IV therapies. Yet, the costs for both types of treatments are relatively the same to insurance companies. This bill could greatly help myeloma patients on oral chemotherapy medications. It would reduce those patients' out-of-pocket costs for their drugs.

Last congress, identical legislation in the House ended with 175 co-sponsors. Our hope is to surpass this in the 116th congress. To accomplish this goal, the International Myeloma Foundation, which leads the CIACC, asks for your help to amplify our efforts during our Hill day. Send a message to Congress about your support for oral parity at the link below.


| INSPIRATION | Father’s Day


Shop for Dad and Give to the IMF at the Same Time

If you shop Amazon this Father’s Day (Sunday, June 16) or for your daily needs, visit and select the International Myeloma Foundation as your preferred charity. When you shop at this link, Amazon will donate a percentage of your total purchase to the IMF, at no added cost to you. Donating to the IMF this Father’s Day is as easy as a point-and-click.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

June 11, 2019
2nd Annual Anti-Cancer Comedy Fundraiser
New York, NY

June 15, 2019
Regional Community Workshop
Detroit, MI

June 29, 2019
Regional Community Workshop
Pittsburgh, PA

August 1, 2019
Brian D. Novis Research Grants

August 23-24, 2019
IMF Patient & Family Seminar
Los Angeles, CA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Celgene Corporation, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.